Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.077 0.04
mRNA pluripotin CTRPv2 pan-cancer AAC -0.073 0.04
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.064 0.04
mRNA erismodegib CTRPv2 pan-cancer AAC 0.078 0.04
mRNA Axitinib CTRPv2 pan-cancer AAC 0.07 0.04
mRNA JW-74 CTRPv2 pan-cancer AAC 0.094 0.04
mRNA narciclasine CTRPv2 pan-cancer AAC 0.068 0.04
mRNA JW-480 CTRPv2 pan-cancer AAC 0.075 0.04
mRNA vincristine CTRPv2 pan-cancer AAC 0.061 0.04
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.063 0.04
Download CSV